Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Alcidion.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Cann to market over-the-counter CBD capsules in Australia
News
Market Highlights and 5 ASX Small Caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: ResApp jumps 65pc on smartphone Covid-19 cough tests
Experts
MoneyTalks: The aerospace, defence and tech sectors are heating up – here are 3 stocks to watch
Experts
Fundie: It’s all about stock valuations in 2022 as momentum trading runs its course
Director Trades
Director Trades: There was only one $1m buy this fortnight, and it came from one of the newest gold producers
Health & Biotech
ScoPo’s Powerplays: Neuren breakthrough, M&A deals, and why EBOS ticks ESG boxes
News
10 at 10: These ASX stocks are delivering some early Christmas cheer this morning
Health & Biotech
ASX Health Stocks: Alcidion wins Aussie government contract, while Resonance seeks US FDA nod
News
10 at 10: These ASX stocks are leaving investors satisfied this morning
Health & Biotech
ASX Health Stocks: Proteomics jumps 13pc on diabetes test
News
Market Highlights and 5 ASX Small Caps to watch on Monday
News
ASX Small Cap Lunch Wrap: Who’s got something to cheer about this morning?
News
Quarterlies Top 5: Who said COVID-19 induced booms in seafood, tech and furniture were over?
News
Closing Bell: Today’s biggest small cap winners on the ASX
News
Market highlights and 5 ASX small caps to watch on Wednesday
Experts